DMR Reading Tools
How to cite item
Is modified FOLFIRINOX a standard regimen for 2nd line chemotherapy for pancreatic cancer after gemcitabine plus nab-paclitaxel failure?—insights from the MPACA-3 trial
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{DMR}{8216}, author = {Matsumoto, T., Yamamura, S., Nagai, H., Satake, H., Yasui, H.}, title = {Is modified FOLFIRINOX a standard regimen for 2nd line chemotherapy for pancreatic cancer after gemcitabine plus nab-paclitaxel failure?—insights from the MPACA-3 trial}, journal = {Digestive Medicine Research}, volume = {5}, number = {0}, year = {2022}, url = {https://dmr.amegroups.org/article/view/8216} }